Clinical Trials Logo
  1. Home
  2. Plantar Wart
  3. NCT05592041
  4. Details
NCT05592041 Clinical Trial

Studying of Natural Constituents' Treatment of Plantar Warts

Plantar Wart Clinical Trial

Official title:
In-vitro and Randomized Controlled Clinical Studying of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported With in Silico Studies

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05592041
Other study ID # Anti-HPV
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date October 20, 2022
Est. completion date January 10, 2023

Study information
Verified date January 2023
Source Deraya University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Moringa banana nigella and Banna coat extract were prepared and formulated in the form of bi gel for transdermal delivery of these plant extracts. The formulation was prepared and charterized for organoleptic charters, morphology, and penetration efficacy. The optimised formulation was assessed clinically on patients suffering from plantar warts. The clinical study was phase 1 and interventional randomised allocation.

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date January 10, 2023
Est. primary completion date December 18, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Male or female patient aged 18 years or more. - Clinical evaluation - Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm Exclusion Criteria: - Patient suspected to be immunocompromised - Patient aged under 18 years - Patient refusing to sign the consent - Pregnant or lactating women

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Banaba Leaf Extract
a herbal extract in the form of Bigel

Locations
Country Name City State
Egypt Soad A. Mohamad Minya

Sponsors (1)
Lead Sponsor Collaborator
Deraya University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Complete clinical remission of the warts Number of warts (counts) 30 days
Primary Clinical assessment of warts curement Diameter of wart in cm 30 days
Secondary Pain asssesment pain was assesed by VAS scoring (0) the least to (5) highest 30 days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05324904 - Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts N/A
Completed NCT00328991 - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts N/A
Completed NCT05115669 - Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts N/A
Recruiting NCT06261684 - Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial. Phase 2/Phase 3
Not yet recruiting NCT05057663 - Intralesional Treatment of Plantar Wart N/A
Recruiting NCT02151630 - Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts Phase 2/Phase 3
Withdrawn NCT04823845 - Plantar Wart Treatment Using Adapalene Gel Early Phase 1
Completed NCT05588999 - Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts Phase 1
Completed NCT01536834 - Safety & Performance Study of Verruca Treatment Device N/A
Recruiting NCT05488860 - Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases N/A
Recruiting NCT05520658 - Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts N/A
Not yet recruiting NCT04654091 - Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts. N/A
Not yet recruiting NCT05599971 - Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts N/A
Not yet recruiting NCT05198180 - Treatment of Plantar Warts Phase 3
Recruiting NCT06214559 - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. N/A
Recruiting NCT03977753 - Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts Phase 4
Completed NCT03183765 - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Phase 4